Efficacy of a Treatment for Chronic Myeloid Leukemia

bcr-abl graph

Summary

Dr. Brian Druker and colleagues monitored white blood cell counts in six patients with chronic myeloid leukemia treated with the drug, STI571, which blocks the activity of the cancer-causing tyrosine kinase BCR-ABL.

9 other people liked this

By downloading, you agree to the permissions to use this file.